![Michael Metzger](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Michael Metzger
Vorstandsvorsitzender bei
SYNDAX PHARMACEUTICALS, INC.
Vermögen: 9 Mio $ am 31.05.2026
Profil
Michael A. Metzger is Chief Executive Officer & Director at Syndax Pharmaceuticals, Inc. since 2022.
Mr. Metzger serves as Director at Northern Westchester Hospital Association.
Mr. Metzger is Independent Director at Pyxis Oncology, Inc. starting in 2024.
Former roles include President, Chief Executive Officer & Director at Regado Biosciences, Inc. from 2014 to 2015; Independent Director at CTI BioPharma Corp.
from 2017 to 2023; Independent Director at Response Genetics, Inc. from 2010 to 2013; Managing Director at Mesa Partners, Inc. from 1997 to 2001; Director at Tarveda Therapeutics, Inc.; Head-Mergers & Acquisitions at Forest Laboratories, Inc. in 2011; Vice President-Corporate Development at Traws Pharma, Inc. from 2001 to 2006; Chief Operating Officer & Executive Vice President at Mersana Therapeutics, Inc. from 2011 to 2013; and President, Chief Executive & Operating Officer at Tobira Therapeutics, Inc. Education includes undergraduate studies at George Washington University and an MBA from The Leonard N Stern School of Business.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 01.06.2026 | 484’843 ( 0.55% ) | 9 Mio $ | 31.05.2026 | |
PYXIS ONCOLOGY, INC. -.--% | 20.04.2026 | 0 ( -.--% ) | - $ | 31.05.2026 |
Aktive Positionen von Michael Metzger
| Unternehmen | Position | Beginn |
|---|---|---|
| SYNDAX PHARMACEUTICALS, INC. | Vorstandsvorsitzender | 03.02.2022 |
| PYXIS ONCOLOGY, INC. | Direktor/Vorstandsmitglied | 10.06.2024 |
Northern Westchester Hospital Association
 Northern Westchester Hospital Association Hospital/Nursing ManagementHealth Services Provides healthcare and medical services | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Michael Metzger
| Unternehmen | Position | Ende |
|---|---|---|
| CTI BIOPHARMA CORP. | Direktor/Vorstandsmitglied | 23.06.2023 |
| TOBIRA THERAPEUTICS INC | Vorstandsvorsitzender | 04.05.2015 |
Regado Biosciences, Inc.
 Regado Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Develops antithrombotic drugs | Vorstandsvorsitzender | 01.05.2015 |
| RESPONSE GENETICS, INC | Direktor/Vorstandsmitglied | - |
| MERSANA THERAPEUTICS | Geschäftsführer | 01.11.2013 |
Ausbildung von Michael Metzger
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
52
Beziehungen ersten Grades
14
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 14 |
|---|---|
Forest Laboratories, Inc.
 Forest Laboratories, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and sells drug products | Health Technology |
CTI BioPharma Corp.
 CTI BioPharma Corp. Pharmaceuticals: MajorHealth Technology Engages in acquisition, development and commercialization of novel targeted therapies for blood-related cancers | Health Technology |
Traws Pharma, Inc.
 Traws Pharma, Inc. BiotechnologyHealth Technology Discovers and develops products for patients with cancer | Health Technology |
Regado Biosciences, Inc.
Regado Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Develops antithrombotic drugs | Health Technology |
Mersana Therapeutics, Inc.
 Mersana Therapeutics, Inc. BiotechnologyHealth Technology Develops and manufactures antibody drug conjugates to improve patient outcomes in multiple oncology indications | Health Technology |
Response Genetics, Inc.
 Response Genetics, Inc. Pharmaceuticals: MajorHealth Technology Provides pharmaceutical and diagnostic services | Health Technology |
Syndax Pharmaceuticals, Inc.
 Syndax Pharmaceuticals, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company | Health Technology |
Mesa Partners, Inc.
 Mesa Partners, Inc. Investment ManagersFinance Provides financial advisory, management, marketing and web business development services | Finance |
George Washington University
 George Washington University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Northern Westchester Hospital Association
Northern Westchester Hospital Association Hospital/Nursing ManagementHealth Services Provides healthcare and medical services | Health Services |
Tarveda Therapeutics, Inc.
 Tarveda Therapeutics, Inc. BiotechnologyHealth Technology Discovers and develops cancer therapeutics and drugs | Health Technology |
The Leonard N Stern School of Business
 The Leonard N Stern School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Tobira Therapeutics, Inc.
 Tobira Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that develops and commercializes therapeutics to treat liver , inflammation, fibrosis & HIV diseases | Health Technology |
Pyxis Oncology, Inc.
 Pyxis Oncology, Inc. Pharmaceuticals: MajorHealth Technology Operates as a preclinical oncology company focused on developing an arsenal of next-generation therapeutics | Health Technology |
